United-Guardian Price to Sales Ratio 2012-2025 | UG
Historical PS ratio values for United-Guardian (UG) over the last 10 years. The current P/S ratio for United-Guardian as of March 11, 2026 is .
| United-Guardian P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-03-11 | 6.61 | 3.02 | |
| 2025-09-30 | 7.58 | $2.19 | 3.46 |
| 2025-06-30 | 7.51 | $2.36 | 3.18 |
| 2025-03-31 | 8.44 | $2.48 | 3.40 |
| 2024-12-31 | 8.70 | $2.65 | 3.28 |
| 2024-09-30 | 14.45 | $2.68 | 5.39 |
| 2024-06-30 | 7.91 | $2.68 | 2.95 |
| 2024-03-31 | 6.77 | $2.52 | 2.69 |
| 2023-12-31 | 6.19 | $2.37 | 2.61 |
| 2023-09-30 | 6.47 | $2.40 | 2.69 |
| 2023-06-30 | 7.02 | $2.26 | 3.10 |
| 2023-03-31 | 7.99 | $2.48 | 3.22 |
| 2022-12-31 | 8.87 | $2.76 | 3.21 |
| 2022-09-30 | 9.40 | $2.96 | 3.18 |
| 2022-06-30 | 12.40 | $3.13 | 3.97 |
| 2022-03-31 | 18.42 | $3.13 | 5.88 |
| 2021-12-31 | 13.33 | $3.03 | 4.39 |
| 2021-09-30 | 11.07 | $2.75 | 4.02 |
| 2021-06-30 | 11.70 | $2.57 | 4.55 |
| 2021-03-31 | 11.49 | $2.41 | 4.76 |
| 2020-12-31 | 10.90 | $2.39 | 4.56 |
| 2020-09-30 | 11.22 | $2.71 | 4.15 |
| 2020-06-30 | 10.97 | $2.92 | 3.75 |
| 2020-03-31 | 10.45 | $2.99 | 3.49 |
| 2019-12-31 | 14.22 | $2.96 | 4.80 |
| 2019-09-30 | 13.34 | $2.72 | 4.92 |
| 2019-06-30 | 13.23 | $2.72 | 4.86 |
| 2019-03-31 | 13.11 | $2.85 | 4.60 |
| 2018-12-31 | 12.56 | $2.93 | 4.29 |
| 2018-09-30 | 10.71 | $3.04 | 3.52 |
| 2018-06-30 | 12.70 | $3.01 | 4.22 |
| 2018-03-31 | 11.49 | $2.98 | 3.85 |
| 2017-12-31 | 11.96 | $2.82 | 4.24 |
| 2017-09-30 | 11.99 | $2.76 | 4.35 |
| 2017-06-30 | 9.50 | $2.82 | 3.37 |
| 2017-03-31 | 8.92 | $2.46 | 3.62 |
| 2016-12-31 | 9.31 | $2.35 | 3.97 |
| 2016-09-30 | 8.60 | $2.12 | 4.05 |
| 2016-06-30 | 9.42 | $2.16 | 4.37 |
| 2016-03-31 | 11.87 | $2.59 | 4.59 |
| 2015-12-31 | 11.00 | $3.05 | 3.61 |
| 2015-09-30 | 10.08 | $3.51 | 2.88 |
| 2015-06-30 | 10.68 | $3.27 | 3.27 |
| 2015-03-31 | 10.20 | $3.02 | 3.38 |
| 2014-12-31 | 10.85 | $2.93 | 3.71 |
| 2014-09-30 | 12.02 | $3.02 | 3.98 |
| 2014-06-30 | 15.40 | $3.21 | 4.79 |
| 2014-03-31 | 15.51 | $3.36 | 4.62 |
| 2013-12-31 | 14.94 | $3.35 | 4.46 |
| 2013-09-30 | 13.04 | $2.97 | 4.39 |
| 2013-06-30 | 12.70 | $3.00 | 4.23 |
| 2013-03-31 | 9.92 | $3.02 | 3.28 |
| 2012-12-31 | 10.06 | $3.01 | 3.34 |
| 2012-09-30 | 9.19 | $3.14 | 2.92 |
| 2012-06-30 | 9.00 | $3.10 | 2.90 |
| 2012-03-31 | 8.75 | $3.17 | 2.76 |
| 2011-12-31 | 7.27 | $3.12 | 2.33 |
| 2011-09-30 | 6.91 | $2.94 | 2.35 |
| 2011-06-30 | 6.76 | $3.05 | 2.21 |
| 2011-03-31 | 6.83 | $2.95 | 2.32 |
| 2010-12-31 | 6.33 | $2.88 | 2.20 |
| 2010-09-30 | 6.31 | $2.94 | 2.14 |
| 2010-06-30 | 5.23 | $2.79 | 1.87 |
| 2010-03-31 | 5.48 | $2.62 | 2.09 |
| 2009-12-31 | 4.95 | $2.68 | 1.84 |
| 2009-09-30 | 3.95 | $2.64 | 1.49 |
| 2009-06-30 | 3.89 | $2.66 | 1.46 |
| 2009-03-31 | 2.85 | $2.66 | 1.07 |
| 2008-12-31 | 3.74 | $2.49 | 1.51 |
| 2008-09-30 | 4.06 | $2.42 | 1.68 |
| 2008-06-30 | 4.59 | $2.25 | 2.04 |
| 2008-03-31 | 3.88 | $2.21 | 1.76 |
| 2007-12-31 | 4.01 | $2.40 | 1.67 |
| 2007-09-30 | 3.83 | $2.41 | 1.59 |
| 2007-06-30 | 4.50 | $2.44 | 1.85 |
| 2007-03-31 | 3.43 | $2.49 | 1.37 |
| 2006-12-31 | 3.31 | $2.27 | 1.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.030B | $0.012B |
| UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |